[Antimicrobial therapy in dermatology]
Cord Sunderkötter1, Mathias Herrmann, Uta Jappe
1Department of Dermatology and Allergology, University Clinic of Ulm; and Department of Dermatology and Venerology, University Hospital Münster, Germany. cord.sunderkoetter@ukmuenster.de
Abstract:
The extensive and sometimes indiscriminate use of antibiotics sometimes without strict indications has led to increases in both bacterial resistance and sensitization of patients. Systemic antibiotics in skin infections are indicated when a severe local infection occurs which spreads into the surrounding tissue or when there are signs of systemic infection. There are special indications in patients with peripheral arterial occlusive disease,diabetes or immunosuppression. Topical use of antibiotics should be abandoned and replaced by antiseptics. The beta-lactam antibiotics are the antibiotics of first choice for many skin infections. They are usually effective, have a well-defined profile of adverse events and most are affordable. Penicillin G or V are the first line treatment for erysipelas. Infections with Staphylococcus aureus are usually treated with isoxazolyl penicillins or second generation cephalosporins. In mixed infections in patients with diabetes or peripheral arterial occlusive disease,the treatment of choice is metronidazole plus beta-lactam-/beta-lactamase inhibitor antibiotics, but quinolones or second generation cephalosporins can also be used, once again with metronidazole. The aim of this review is to define the indications for antibiotics in dermatology, to highlight their modes of action and adverse effects and to make suggestions for rational antibiotic therapy in cutaneous infections frequently encountered in the practice of dermatology.
Insights
Antibiotic overuse in skin infections fuels resistance. This review advocates for rational antibiotic use in dermatology, prioritizing topical antiseptics and specific beta-lactam antibiotics for common bacterial infections.
Area of Science:
- Dermatology
- Infectious Diseases
- Pharmacology
Context:
- Extensive and indiscriminate antibiotic use has increased bacterial resistance and patient sensitization.
- Systemic antibiotics are indicated for severe or spreading skin infections, especially in patients with diabetes, immunosuppression, or peripheral arterial occlusive disease.
- Topical antibiotic use should be replaced by antiseptics.
Purpose:
- To define antibiotic indications in dermatology.
- To highlight antibiotic mechanisms of action and adverse effects.
- To provide guidance for rational antibiotic therapy in common cutaneous infections.
Summary:
- Beta-lactam antibiotics are often first-line for skin infections due to efficacy, safety, and affordability.
- Penicillin G or V for erysipelas; isoxazolyl penicillins or cephalosporins for Staphylococcus aureus.
- Mixed infections in high-risk patients may require metronidazole plus beta-lactam/beta-lactamase inhibitors, quinolones, or cephalosporins.
Impact:
- Promotes judicious antibiotic selection to combat resistance.
- Improves patient outcomes by ensuring appropriate treatment for skin infections.
- Reduces adverse drug events and healthcare costs associated with antibiotic misuse.
Related Concept Videos
Hand hygiene
Hand washing...
Clinical Significance of Antibiotic Resistance
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Antimicrobial Effectiveness
Acne Infection
Antifungal Agents

